Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.

Cesi V, Casciati A, Sesti F, Tanno B, Calabretta B, Raschellà G.

Cell Cycle. 2011 Dec 1;10(23):4149-61. doi: 10.4161/cc.10.23.18346. Epub 2011 Dec 1.

PMID:
22101269
2.

Activation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylation.

Pieraccioli M, Imbastari F, Antonov A, Melino G, Raschellà G.

Cell Cycle. 2013 Jul 15;12(14):2309-20. doi: 10.4161/cc.25405.

3.

Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.

Hugo HJ, Pereira L, Suryadinata R, Drabsch Y, Gonda TJ, Gunasinghe NP, Pinto C, Soo ET, van Denderen BJ, Hill P, Ramsay RG, Sarcevic B, Newgreen DF, Thompson EW.

Breast Cancer Res. 2013 Nov 27;15(6):R113. doi: 10.1186/bcr3580.

4.

MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.

Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J.

Oncogene. 2013 Dec 12;32(50):5614-24. doi: 10.1038/onc.2013.322. Epub 2013 Aug 19.

6.

Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.

Sehrawat A, Singh SV.

Cancer Prev Res (Phila). 2011 Jul;4(7):1107-17. doi: 10.1158/1940-6207.CAPR-10-0306. Epub 2011 Apr 4.

7.

CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.

Mitra P, Yang RM, Sutton J, Ramsay RG, Gonda TJ.

Oncotarget. 2016 Feb 23;7(8):9069-83. doi: 10.18632/oncotarget.6997.

8.
9.

Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin.

Tanno B, Sesti F, Cesi V, Bossi G, Ferrari-Amorotti G, Bussolari R, Tirindelli D, Calabretta B, Raschellà G.

J Biol Chem. 2010 Sep 17;285(38):29434-45. doi: 10.1074/jbc.M109.089045. Epub 2010 Jul 11.

10.

MYB suppresses differentiation and apoptosis of human breast cancer cells.

Drabsch Y, Robert RG, Gonda TJ.

Breast Cancer Res. 2010;12(4):R55. doi: 10.1186/bcr2614. Epub 2010 Jul 26.

11.

Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.

Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.

Carcinogenesis. 2013 Apr;34(4):874-84. doi: 10.1093/carcin/bgs396. Epub 2012 Dec 28.

PMID:
23275155
12.
13.

Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.

Sundqvist A, Zieba A, Vasilaki E, Herrera Hidalgo C, Söderberg O, Koinuma D, Miyazono K, Heldin CH, Landegren U, Ten Dijke P, van Dam H.

Oncogene. 2013 Aug 1;32(31):3606-15. doi: 10.1038/onc.2012.370. Epub 2012 Aug 27.

PMID:
22926518
14.

Cyclic AMP enhances TGFβ responses of breast cancer cells by upregulating TGFβ receptor I expression.

Oerlecke I, Bauer E, Dittmer A, Leyh B, Dittmer J.

PLoS One. 2013;8(1):e54261. doi: 10.1371/journal.pone.0054261. Epub 2013 Jan 18.

15.

Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.

Wendt MK, Smith JA, Schiemann WP.

Oncogene. 2010 Dec 9;29(49):6485-98. doi: 10.1038/onc.2010.377. Epub 2010 Aug 30.

16.

Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.

Richards EJ, Zhang G, Li ZP, Permuth-Wey J, Challa S, Li Y, Kong W, Dan S, Bui MM, Coppola D, Mao WM, Sellers TA, Cheng JQ.

J Biol Chem. 2015 Mar 13;290(11):6857-67. doi: 10.1074/jbc.M114.610915. Epub 2015 Jan 20. Erratum in: J Biol Chem. 2016 Oct 21;291(43):22860.

17.

Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.

Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, Taya Y.

Cancer Res. 2008 Jul 1;68(13):5104-12. doi: 10.1158/0008-5472.CAN-07-5680.

18.

Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.

Ziegler E, Hansen MT, Haase M, Emons G, Gründker C.

Breast Cancer Res Treat. 2014 Nov;148(2):269-77. doi: 10.1007/s10549-014-3159-4. Epub 2014 Oct 8. Erratum in: Breast Cancer Res Treat. 2016 Feb;156(1):209-10.

PMID:
25292421
19.

Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors.

Cherlet T, Murphy LC.

Mol Cell Biochem. 2007 Dec;306(1-2):33-42. Epub 2007 Jul 28.

PMID:
17660955
20.

Identification and regulation of c-Myb target genes in MCF-7 cells.

Quintana AM, Liu F, O'Rourke JP, Ness SA.

BMC Cancer. 2011 Jan 25;11:30. doi: 10.1186/1471-2407-11-30.

Supplemental Content

Support Center